RecruitingNot ApplicableNCT05477277

Adverse Outcomes and Mortality in Liver Transplant


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Nov 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • All patients with end-stage liver disease undergoing evaluation for liver transplantation
  • Patient clinically indicated for MRI during transplant candidacy evaluation
  • Adult

Exclusion Criteria1

  • \. Contra indication to MRI

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMAsS

Add MAsS to standard of care MRI scan


Locations(1)

Mayo Clinic Arizona

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05477277


Related Trials